VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema.

VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema.

Although lymphedema is a common clinical condition, treatment for this disabling condition remains limited and largely ineffective. Recently, it has been reported that overexpression of VEGF-C correlates with increased lymphatic vessel growth (lymphangiogenesis). However, the effect of VEGF-C-induce...

詳細記述

書誌詳細
主要な著者: Yoon, Y, Murayama, T, Gravereaux, E, Tkebuchava, T, Silver, M, Curry, C, Wecker, A, Kirchmair, R, Hu, C, Kearney, M, Ashare, A, Jackson, D, Kubo, H, Isner, J, Losordo, D
フォーマット: Journal article
言語:English
出版事項: 2003

類似資料